Drugs / sulfadoxine/pyrimethamine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00164255 | Jan 2003 → Jun 2009 | Plasmodium falciparum malaria | Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sulfadoxine/pyrimethamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00164255 ↗ |
| Known as | sulphadoxine-pyrimethamine | “The World Health Organization (WHO) recommends intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) for pregnant women living in areas of...” PMID 39324693 ↗ Sep 2024 |